Biologic, Immunocytochemical, and Cytogenetic Characterization of Two New Human Melanoma Cell Lines: IIB‐MEL‐LES and IIB‐MEL‐IAN
Two human melanoma cell lines, derived from metastases of two patients with epithelioid malignant amelanotic melanomas, and designated IIB‐MEL‐LES and IIB‐MEL‐IAN, have been established. Both cell lines have been in continuous culture over 2 years and were propagated continuously for 85 and 75 seria...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
1995
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 15994caa a22016217a 4500 | ||
|---|---|---|---|
| 001 | PAPER-16584 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518204736.0 | ||
| 008 | 190411s1995 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-0029314234 | |
| 024 | 7 | |2 cas |a DNA, 9007-49-2; DNA Restriction Enzymes, EC 3.1.21.-; DNA, Neoplasm; ganglioside, GD2, 65988-71-8; ganglioside, GD3, 62010-37-1; Gangliosides; Histocompatibility Antigens Class I; HLA-DR Antigens; S100 Proteins; Vimentin | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 100 | 1 | |a KAIRIYAMA, C. | |
| 245 | 1 | 0 | |a Biologic, Immunocytochemical, and Cytogenetic Characterization of Two New Human Melanoma Cell Lines: IIB‐MEL‐LES and IIB‐MEL‐IAN |
| 260 | |c 1995 | ||
| 270 | 1 | 0 | |m MORDOH, J.; Instituto de Investigaciones Bioquimicas "Fundacion Campomar", Patricias Argentinas 435, Buenos Aires, 1405, Argentina |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Azumi, N., Battifora, H., The distribution of vimentin and keratin in epithelial and non epithelial neoplasms. A comprehensive immunohistochemical study on formalin and alcohol fixed tumors. Am. J. Clin (1987) Pathol., 88, pp. 286-296 | ||
| 504 | |a Balaban, G.B., Herlyn, M., Clark, W.H., Jr, Nowell, P.C., Karyotypic evolution in human malignant melanoma (1984) Cancer Genet. Cytogenet, 19, pp. 113-122 | ||
| 504 | |a Becher, R., Gibas, Z., Sandberg, A.A., Chromosome 6 in malignant melanoma (1983) Cancer Genet. Cytogenet., 9, pp. 173-175 | ||
| 504 | |a Brodeur, G.M., Fong, C., Molecular biology and genetics of human neuroblastoma (1989) Cancer Genet. Cytogenet., 41, pp. 153-174 | ||
| 504 | |a Bystryn, J‐C., Henn, M., Li, J., Shroba, S., Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine (1992) Cancer Res., 52, pp. 5948-5953 | ||
| 504 | |a Chomczynsky, P., Sechi, N., Single step method of RNA isolation by acid guanidinium thiocyanate‐phenol‐chloroform (1987) Anal. Biochem., 162, pp. 156-159 | ||
| 504 | |a Colcher, D., Horan Hand, P., Nuti, M., Schlom, J., Differential binding to human mammary and non mammary tumors of monoclonal antibodies reactive with carcinoembryonic antigen (1983) Cancer Invest., 1, pp. 127-138 | ||
| 504 | |a D'Alessandro, G., Zardani, I., Grace, J., McCarthy, W.H., Hersey, P., Immunohistological evaluation of MHC class I and II antigen expression on nevi and melanoma: Relation to biology of melanoma (1987) Pathology, 19, pp. 339-346 | ||
| 504 | |a Dippold, W.G., Lloyd, K.O., Li, L.T.C., Ikeda, H., Oettgen, H.F., Old, L.J., Cell surface antigens of human malignant melanoma: Definition of 6 antigenic systems with mouse monoclonal antibodies (1980) Proc. Natl. Acad. Sci. USA., 77, pp. 6114-6118 | ||
| 504 | |a Dracopoli, N.C., Harnett, P., Bale, S., Stanger, B.Z., Tucker, M.A., Housman, D.E., Kefford, R.F., Loss of alleles from distal short arm of chromosome 1 occurs late in melanoma tumor progression (1989) Proc. Natl. Acad. Sci. USA, 86, pp. 4614-4618 | ||
| 504 | |a Duray, P., Palozzo, J., Gown, A.M., Ohuchi, N., Melanoma cell heterogeneity (1988) Cancer, 61, pp. 2460-2468 | ||
| 504 | |a Guerra, L., Mordoh, J., Slavutsky, I., Larripa, I., Medrano, E.E., characterization of IIB‐MEL‐J: a new and highly heterogeneous human melanoma cell line (1989) Pigment Cell Res., 2, pp. 504-509 | ||
| 504 | |a Hamburguer, A.W., Salmon, S.E., Primary bioassay of human tumor stem cells (1977) Science, 197, pp. 461-463 | ||
| 504 | |a Heim, S., Mandhal, N., Arheden, K., Giovanella, B.C., Ock Yim, S., Sthelin, J.S., Jr, Mitelman, F., Multiple karyotypic abnormalities, including structural rearrangements of 11p, in cell lines from malignant melanomas (1988) Cancer Genet. Cytogenet., 35, pp. 5-20 | ||
| 504 | |a Hendrix, M.J.C., Seftor, E.A., Chu, Y‐W., Seftor, R.E.B., Nagle, R.B., McDaniel, K.M., Leong, S.P.L., Stetler‐Stevenson, W., Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential (1992) J. Natl. Cancer Inst., 84, pp. 165-174 | ||
| 504 | |a Herlyn, M., Thurin, J., Balaban, G., Bennicelli, J.L., Herlyn, D., Elder, D.E., Bondi, E., Koprowski, H., Characteristics of cultured human melanocytes isolated from different stages of tumor progression (1985) Cancer Res., 45, pp. 5670-5676 | ||
| 504 | |a Human Gene Mapping 11. London Conference. Eleventh International Workshops on Human Gene Mapping (1991) Cytogenet. Cell Genet., 58, pp. 1-21 | ||
| 504 | |a Mitelman, F. Guidelines for Cancer Cytogenetics (1991) Supplement to An International System for Human Cytogenetic Nomenclature, , F. Mitelman, (ed);, S. Karger, Basel | ||
| 504 | |a Jorgensen, J.L., Reay, P.A., Ehrich, E.W., Davis, M.M., Molecular components of T‐cell recognition (1992) Ann. Rev. Immunol., 10, pp. 835-873 | ||
| 504 | |a Kakati, S., Song, S.Y., Sandberg, A.A., Chromosome and causation of human cancer and leukemia (1977) XXII. Karyotypic changes in malignant melanoma. Cancer, 40, pp. 1173-1181 | ||
| 504 | |a Kawakami, Y., Zakut, R., Topalian, S.L., Stotter, H., Rosemberg, S.A., Shared human melanoma antigens: recognition by tumor‐infiltrating lymphocytes in HLA‐A2.1 transfected melanomas (1992) J. Immunol., 148, p. 638 | ||
| 504 | |a Kopf, I., Stierner, U., Islam, Q., Delle, U., Kindblom, L.‐G., Martinsson, T., Characterization of four melanoma cell lines with electron microscopy, immunocytochemistry, cytogenetics, flow cytometry, and Southern analysis (1992) Cancer Genet. Cytogenet., 62, pp. 111-123 | ||
| 504 | |a Mathew, C.G.P., Smith, B.A., Thorpe, K., Wong, Z., Royle, N.J., Jeffreys, A.J., Ponder, B.A., Depletion of genes on chromosome 1 in endocrine neoplasia (1987) Nature (Lond.), 328, pp. 524-527 | ||
| 504 | |a McClay, E.F., Mastrangelo, M.J., Bellet, R.E., Berd, D., Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma (1987) Cancer Treat. Rep., 71, pp. 465-469 | ||
| 504 | |a McCulloch, P.B., Dent, P.B., Hayes, P.R., Liao, S.‐K., Commonly and individually specific chromosomal characteristics of cultured human melanoma (1976) Cancer Res., 36, pp. 398-404 | ||
| 504 | |a Meyskens, F.L., Fuller, B.B., Characterization of the effects of different retinoids on the growth and differentiation of a human melanoma cell line and selected subclones (1980) Cancer Res., 40, pp. 2194-2196 | ||
| 504 | |a Miettinem, M., Franssila, K., Immunohistochemical spectrum of malignant melanoma: The common presence of keratins (1989) Lab. Invest, 61, pp. 623-628 | ||
| 504 | |a Mitelman, F., (1991) Catalog of human chromosome aberrations in cancer, , Wiley‐Liss, Inc., New York | ||
| 504 | |a Morton, D.L., Foshag, L.J., Hoon, D.S.B., Nizze, A., Wanek, L.A., Chang, C., Davtyan, D.G., We, R., Prolongation of survival in metastatic melanoma after specific immunotherapy with a new polyvalent melanoma vaccine (1992) Ann. Surg., 216, pp. 463-482 | ||
| 504 | |a Muraro, R., Wunderlich, D., Thor, A., Lundi, J., Noguchi, P., Cunningham, R., Schlom, J., Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinoma versus normal adult tissues (1985) Cancer Res., 45, pp. 5769-5780 | ||
| 504 | |a Natali, P.G., Nicotra, M.R., Nuti, M., Bigotti, G., Calabro, A., Schlom, J., Giacomini, P., Molecular profile, tissue distribution and prognostic evaluation of a human melanoma‐carcinoma antigen recognized by the murine monoclonal antibody B1.1 (1988) Int. J. Biol. Markers, 3, pp. 211-220 | ||
| 504 | |a Parham, P., Barnstable, C.J., Bodmer, W.F., Use of monoclonal antibody (W6/32) in structural studies of HLA‐A,B,C antigens (1979) J. Immunol., 123, pp. 342-349 | ||
| 504 | |a Pathak, S., Cytogenetics of solid tumors: renal cell carcinoma, malignant melanoma, retinoblastoma, and Wilms' tumor (1986) The human oncogenic viruses, pp. 43-87. , Albert Luderer, Howell Weetall, The Humana Press, Inc | ||
| 504 | |a Pathak, S., Drwinga, H.L., Hsu, T.C., Involvement of chromosome 6 rearrangements in human malignant melanoma cell lines (1983) Cytogenet. Cell Genet., 36, pp. 573-579 | ||
| 504 | |a Pedersen, M.I., Bennet, J.W., Wang, N., Nonrandom chromosome structural aberrations and oncogene loci in human malignant melanoma (1986) Cancer Genet. Cytogenet., 20, pp. 11-27 | ||
| 504 | |a Pukel, C.S., Lloyd, K.O., Travassos, L.R., Dippold, W.G., Oettgen, H.F., Old, L.J., GD3, a prominent ganglioside of human melanoma: detection and characterization by mouse monoclonal antibody (1982) J. Exp. Med., 155, pp. 1133-1147 | ||
| 504 | |a Seabright, M., Rapid banding technique for human chromosomes (1971) Lancet, 2, pp. 971-972 | ||
| 504 | |a Semple, T.U., More, G.E., Morgan, R.T., Woods, L.K., Quinn, L.A., Multiple cell lines from patients with malignant melanoma Morphology, karyology, and biochemical analysis (1982) J. Natl. Cancer Inst., 68, pp. 365-380 | ||
| 504 | |a Shin, S.I., Use of nude mice for tumorigenicity testing and mass propagation (1979) Meth. Enzymol., 58, pp. 370-379 | ||
| 504 | |a Sorin, I., Bravo, A.I., Podhajcer, O.L., Bover, L., Sousa Martinez, F., Guman, N., Mordoh, J., Analysis of DNA synthesis and carcinoembryonic antigen expression in human breast cancer (1988) J. Exp. Clin. Cancer Res., 7, pp. 35-42 | ||
| 504 | |a Teyssier, J.R., Nonrandom chromosomal changes in human solid tumors: Applications of an improved culture method (1987) J. Natl. Cancer Inst, 79, pp. 1189-1198 | ||
| 504 | |a Trejdosiewics, L.K., Southgate, J., Kemshead, J.T., Hodges, G.M., Phenotypic analysis of cultured melanoma cells. Expression of cytokeratin‐type intermediate filaments by the M5 human melanoma cell line (1986) Exp. Cell Res., 164, pp. 388-398 | ||
| 504 | |a Trent, J.M., Stanbridge, E., McBride, H.L., Messe, E.U., Casey, G., Araujo, D.E., Witkowski, C.M., Nable, R.B., Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6 (1990) Science, 247, pp. 568-571 | ||
| 504 | |a Van Duinen, S.G., Ruiter, D.J., Broecker, E.B., Van der Velde, E.A, Sorg, C., Welvaart, K., Ferrone, S., Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma (1988) Cancer Res., 48, pp. 1019-1025 | ||
| 504 | |a Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., de Plaen, E., Van den Eynde, B, Knuth, A., Boon, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma (1991) Science, 254, pp. 1643-1647 | ||
| 504 | |a Wolfel, T., Klehmann, E., Mullre, C., Schutt, K.H., Zum Bushenfelde, Knuth, A., Lysis of human melanoma cells by autologous cytolytic T cell clones: identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens. J. Exp (1989) Med., 170, p. 797 | ||
| 504 | |a Zakut, R., Topalian, S., Kawakami, Y., Mancini, M., Eliyahu, S., Rosemberg, S., Differential expression of MAGE‐1, ‐2 and ‐3 messenger RNA in transformed and normal human cell lines (1993) Cancer Res., 52, pp. 5-8 | ||
| 520 | 3 | |a Two human melanoma cell lines, derived from metastases of two patients with epithelioid malignant amelanotic melanomas, and designated IIB‐MEL‐LES and IIB‐MEL‐IAN, have been established. Both cell lines have been in continuous culture over 2 years and were propagated continuously for 85 and 75 serial passages, respectively. Morphologically, IIB‐MEL‐LES is composed predominantly of spindle shaped cells, whereas IIB‐MEL‐IAN grows as a monolayer of cuboid and stellate shaped cells with many rounded cells in suspension. Immunocytochemical studies revealed that both cell lines express S‐100 protein, vimentin, and GD3 and GD2 gangliosides but are negative for keratin and collagen. Both cell lines express HLA class I and HLA‐DR antigens in variable proportions. The MAGE‐1 gene is expressed only by the IIB‐MEL‐IAN cell line, as revealed by PCR analysis. Cytogenetic analysis of both cell lines revealed abnormal karyotypes; the modal chromosome numbers of IIB‐MEL‐LES and IIB‐MEL‐IAN were 48 and 81, respectively. IIB‐MEL‐LES cells presented rearrangements in chromosomes 1, 14 and X, gains in chromosomes 10,20, and 21 losses in chromosomes 15 and Y. The most frequent markers observed in IIB‐MEL‐IAN cells were 7q+, 10p+, 2p+, i(6p), 2q+, and 10q‐. Clonal gains were observed in chromosomes 12 and 21, whereas losses were seen in chromosomes 1, 2, 3, 4, 6, 7, 11, and 17. Both cell lines were capable of forming colonies in soft agar and developed tumors when transplanted into nude mice, reproducing and maintaining the characteristics of the original tumors. These cell lines and their xenografts appear to provide useful systems for studying the biology, genetics and histogenesis of human malignant melanoma and could be utilized for the development of melanoma vaccines. Copyright © 1995, Wiley Blackwell. All rights reserved |l eng | |
| 593 | |a Institute de Investigaciones Bioquimicas, Fundacion Campomar" and Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, 1405, Argentina | ||
| 593 | |a Instituto de Investigaciones Hematologicas “M.R. Castex” Academia Nacional de Medicina, Buenos Aires, 1425, Argentina | ||
| 593 | |a Hospital Eva Peron, Buenos Aires, 1650, Argentina | ||
| 690 | 1 | 0 | |a ANTIGENS |
| 690 | 1 | 0 | |a CYTOGENETICS |
| 690 | 1 | 0 | |a MAGE PCR |
| 690 | 1 | 0 | |a MELANOMA CELL LINES |
| 690 | 1 | 0 | |a DNA |
| 690 | 1 | 0 | |a GANGLIOSIDE |
| 690 | 1 | 0 | |a GANGLIOSIDE, GD2 |
| 690 | 1 | 0 | |a GANGLIOSIDE, GD3 |
| 690 | 1 | 0 | |a HLA ANTIGEN CLASS 1 |
| 690 | 1 | 0 | |a HLA DR ANTIGEN |
| 690 | 1 | 0 | |a PROTEIN S 100 |
| 690 | 1 | 0 | |a RESTRICTION ENDONUCLEASE |
| 690 | 1 | 0 | |a VIMENTIN |
| 690 | 1 | 0 | |a ADULT |
| 690 | 1 | 0 | |a AMELANOTIC MELANOMA |
| 690 | 1 | 0 | |a ANIMAL |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a CANCER TRANSPLANTATION |
| 690 | 1 | 0 | |a CASE REPORT |
| 690 | 1 | 0 | |a CELL CULTURE |
| 690 | 1 | 0 | |a CHEMISTRY |
| 690 | 1 | 0 | |a GENETICS |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a IMMUNOHISTOCHEMISTRY |
| 690 | 1 | 0 | |a IMMUNOPHENOTYPING |
| 690 | 1 | 0 | |a KARYOTYPING |
| 690 | 1 | 0 | |a MALE |
| 690 | 1 | 0 | |a METASTASIS |
| 690 | 1 | 0 | |a MOLECULAR GENETICS |
| 690 | 1 | 0 | |a MOUSE |
| 690 | 1 | 0 | |a NUCLEOTIDE SEQUENCE |
| 690 | 1 | 0 | |a NUDE MOUSE |
| 690 | 1 | 0 | |a PATHOLOGY |
| 690 | 1 | 0 | |a ADULT |
| 690 | 1 | 0 | |a ANIMALS |
| 690 | 1 | 0 | |a BASE SEQUENCE |
| 690 | 1 | 0 | |a DNA RESTRICTION ENZYMES |
| 690 | 1 | 0 | |a DNA, NEOPLASM |
| 690 | 1 | 0 | |a GANGLIOSIDES |
| 690 | 1 | 0 | |a HISTOCOMPATIBILITY ANTIGENS CLASS I |
| 690 | 1 | 0 | |a HLA-DR ANTIGENS |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a IMMUNOHISTOCHEMISTRY |
| 690 | 1 | 0 | |a IMMUNOPHENOTYPING |
| 690 | 1 | 0 | |a KARYOTYPING |
| 690 | 1 | 0 | |a MALE |
| 690 | 1 | 0 | |a MELANOMA, AMELANOTIC |
| 690 | 1 | 0 | |a MICE |
| 690 | 1 | 0 | |a MICE, NUDE |
| 690 | 1 | 0 | |a MOLECULAR SEQUENCE DATA |
| 690 | 1 | 0 | |a NEOPLASM METASTASIS |
| 690 | 1 | 0 | |a NEOPLASM TRANSPLANTATION |
| 690 | 1 | 0 | |a S100 PROTEINS |
| 690 | 1 | 0 | |a TUMOR CELLS, CULTURED |
| 690 | 1 | 0 | |a VIMENTIN |
| 700 | 1 | |a SLAVUTSKY, I. | |
| 700 | 1 | |a LARRIPA, I. | |
| 700 | 1 | |a MORVILLO, V. | |
| 700 | 1 | |a BRAVO, A.I. | |
| 700 | 1 | |a BOVER, L. | |
| 700 | 1 | |a PODHAJCER, O.L. | |
| 700 | 1 | |a MORDOH, J. | |
| 773 | 0 | |d 1995 |g v. 8 |h pp. 121-131 |k n. 3 |p Pigm. Cell Res. |x 08935785 |w (AR-BaUEN)CENRE-6494 |t Pigment Cell Research | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029314234&doi=10.1111%2fj.1600-0749.1995.tb00652.x&partnerID=40&md5=1fae17f5436c59dec4479762b2fa64c5 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1111/j.1600-0749.1995.tb00652.x |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_08935785_v8_n3_p121_KAIRIYAMA |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_08935785_v8_n3_p121_KAIRIYAMA |y Registro en la Biblioteca Digital |
| 961 | |a paper_08935785_v8_n3_p121_KAIRIYAMA |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 77537 | ||